Skip to content

Lovesac LOVE Common Stock Shares Outstanding

Common Stock Shares Outstanding at other companies

CTO
Citius Oncology, Inc.CTOR
$5.39M0.0%
OPA
OPAL Fuels Inc.OPAL
$1.11M
Where Food Comes From logo
Where Food Comes FromWFCF
$252.72M-22.1%
Delcath Systems logo
Delcath SystemsDCTH
$13.93M-56.3%
NVE Corporation logo
NVE CorporationNVEC
$123.39K+31.0%
Viemed Healthcare, Inc. logo
Viemed Healthcare, Inc.VMD
$13.12M+51.2%

Other financials

Income statement

See full
Revenue$138.2M-0.1%
Gross profit$72.0M-3.2%
Operating income-$17.4M-16.2%
Net income-$11.1M-2.3%
EPS (diluted)-$0.76-4.1%

Balance sheet

See full
Cash & equivalents$57.0M+112%
Total debt$190.9M-0.4%
Total equity$205.5M+2.1%
Total assets$501.0M+3.6%

Cash flow

See full
Operating cash flow-$35.4M+14.6%
CapEx$5.0M-41.4%
Free cash flow-$40.4M+19.2%

Valuation

See full
Market cap$244.32M-8.7%
Enterprise value$378.19M-12.5%
P/E64.1×+44.5×
P/S0.4×0.0×

Profitability

See full
Gross margin56.1%-2.2pp
Operating margin0.4%-2.0pp
Net margin0.5%-1.4pp
FCF margin5.1%+3.8pp

Returns & leverage

See full
Return on equity1.9%-4.9pp
Debt / equity0.9×0.0×
Current ratio1.6×-0.1×

Where this comes from

Reported directly by Lovesac in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.

The official record: Lovesac’s 10-K, filed April 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lovesac's common stock shares outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lovesac's common stock shares outstanding?
Lovesac (LOVE) reported common stock shares outstanding of $0 in Q4 2025.
What is the long-term trend for Lovesac's common stock shares outstanding?
Over 5 years (2021 to 2026), Lovesac's common stock shares outstanding has grown at a -100.0% compound annual growth rate (CAGR), from $9.14M to $0.
What does common stock shares outstanding mean?
This represents the total number of common shares held by all shareholders, including institutional investors and insiders. It serves as the denominator for calculating earnings per share and is a key indicator of potential equity dilution. Changes in this figure reflect share repurchases, new issuances, or conversion of convertible securities.